Ticker LaunchSPAC · Searching for a target · OACC
Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences (OACC) is a blank-check company (SPAC) that raised $175M in its initial public offering on Oct 24, 2024, listing on Nasdaq Global Market. It has not announced a definitive business combination agreement. Kirkland & Ellis advised the SPAC and White & Case advised the underwriters on the IPO.
- Status
- Searching for a target
- Ticker
- OACC
- IPO date
- Oct 24, 2024
- IPO size
- $175M
- IPO exchange
- Nasdaq Global Market
- SPAC counsel (IPO)
- Kirkland & Ellis and Walkers
- Underwriters' counsel (IPO)
- White & Case
More on this SPAC for subscribers
- Trust balance and value per share
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Oct 24, 2024
- All filings on EDGAR CIK 2029769
Other SPAC IPOs from 2024
- Inflection Point Acquisition Corp. IV (f/k/a Bleichroeder Acquisition Corp. I)Nov 1, 2024 · $250M
- Bold Eagle Acquisition Corp.Oct 24, 2024 · $250M
- Charlton Aria Acquisition CorpOct 24, 2024 · $75M
- Aldel Financial II Inc.Oct 23, 2024 · $200M
- Rising Dragon Acquisition Corp.Oct 11, 2024 · $50M
- Cohen Circle Acquisition Corp. I (fka FTAC Artemis Acquisition Corp.)Oct 11, 2024 · $200M